Clinical trial: switch to combined mycophenolate mofetil and minimal dose calcineurin inhibitor in stable liver transplant patients – assessment of renal and allograft function, cardiovascular risk factors and immune monitoring
V. R. CICINNATI; Z. YU; C. G. KLEIN; G. C. SOTIROPOULOS; F. SANER; M. MALAGÓ; A. FRILLING; G. GERKEN; C. E. BROELSCH; S. BECKEBAUM
作者V. R. CICINNATI; Z. YU; C. G. KLEIN; G. C. SOTIROPOULOS; F. SANER; M. MALAGÓ; A. FRILLING; G. GERKEN; C. E. BROELSCH; S. BECKEBAUM